Open access · CC-BY
via OpenAlex
Metabolic Effects of Testosterone Replacement Therapy in Patients with Type 2 Diabetes Mellitus or Metabolic Syndrome: A Meta-Analysis
Shuying Li, Yaling Zhao, Yufan Yang, Xi Wang, Min Nie, Xueyan Wu, Jiangfeng Mao, Franco Veglio
International Journal of Endocrinology · 2020 · ▲ 54 citations
Abstract
Background. Testosterone replacement therapy (TRT) is commonly used for the treatment of hypogonadism in men, which is often associated with type 2 diabetes mellitus (T2DM) and metabolic syndrome (Mets). Recent compiling evidence shows that TRT has beneficial metabolic effects on these patients. Objective. A meta-analysis has been conducted to evaluate the effects of TRT on cardiovascular metabolic factors. Methods. We conducted a systemic search on PubMed, Embase, Cochrane Library, Wanfang, and CNKI and selected randomized controlled trials (RCTs) to include. The efficacy of TRT on glycemia, insulin sensitivity, lipid profile, and body weight was meta-analyzed by Review Manager. Results. A total of 18 RCTs, containing 1415 patients (767 in TRT and 648 in control), were enrolled for the meta-analysis. The results showed that TRT could reduce HbA1c (MD = −0.67, 95% CI −1.35, −0.19, and P = 0.006 ) and improve HOMA-IR (homeostatic model assessment of insulin resistance) (SMD = −1.94, 95% CI −2.65, −1.23, and P < 0.0001 ). TRT could also decrease low-density lipoprotein (SMD = −0.50, 95% CI −0.82, −0.90, and P = 0.002 ) and triglycerides (MD = −0.64, 95% CI −0.91, −0.36, and P < 0.0001 ). In addition, TRT could reduce body weight by 3.91 kg (MD = −3.91, 95% CI −4.14, −3.69, and P < 0.00001 ) and waist circumference by 2.8 cm (MD −2.80, 95% CI −4.38, −1.21 and P = 0.0005 ). Erectile dysfunction (measured by IIEF-5) did not improve, while aging-related symptoms (measured by AMS scores) significantly improved. Conclusions. TRT improves glycemic control, insulin sensitivity, and lipid parameters in hypogonadism patients with T2DM and MetS, partially through reducing central obesity.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1155/2020/4732021
- Canonical
- link ↗
- Fetched
- 2026-10-20 MST
Cite this
APA
Li, S., Zhao, Y., Yang, Y., Wang, X., Nie, M., Wu, X., Mao, J., & Veglio, F. (2020). Metabolic Effects of Testosterone Replacement Therapy in Patients with Type 2 Diabetes Mellitus or Metabolic Syndrome: A Meta-Analysis. <em>International Journal of Endocrinology</em>. https://doi.org/10.1155/2020/4732021
Vancouver
Li S, Zhao Y, Yang Y, Wang X, Nie M, Wu X, et al. Metabolic Effects of Testosterone Replacement Therapy in Patients with Type 2 Diabetes Mellitus or Metabolic Syndrome: A Meta-Analysis. International Journal of Endocrinology. 2020. doi:10.1155/2020/4732021.
BibTeX
@article{shuying2020Metabo,
title = {Metabolic Effects of Testosterone Replacement Therapy in Patients with Type 2 Diabetes Mellitus or Metabolic Syndrome: A Meta-Analysis},
author = {Shuying Li and Yaling Zhao and Yufan Yang and Xi Wang and Min Nie and Xueyan Wu and Jiangfeng Mao and Franco Veglio},
journal = {International Journal of Endocrinology},
year = {2020},
doi = {10.1155/2020/4732021},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
International Journal of Applied Exercise Physiology 2017
Open access · CC-BY
The effect of 8 weeks of Circuit Resistance Training on metabolic syndrome risk factors and body composition in women over age 50 with diabetes mellitus type 2
Diabetes Care 2011
Open access · CC-BY
Testosterone Replacement in Hypogonadal Men With Type 2 Diabetes and/or Metabolic Syndrome (the TIMES2 Study)
Diabetes Care 2005
Open access · OA
Effect of Sibutramine on Weight Management and Metabolic Control in Type 2 Diabetes
Journal of Diabetes Investigation 2013
Open access · OA
Metabolic syndrome as a predictor of type 2 diabetes, and its clinical interpretations and usefulness
Gender Medicine 2010
Citation only
Sex-Specific differences in metabolic control, cardiovascular risk, and interventions in patients with type 2 diabetes mellitus
Journal of Medical and Oral Biosciences 2026
Citation only